Nanobiotix S.A.

NASDAQ: NBTX · Real-Time Price · USD
8.14
-0.06 (-0.73%)
At close: Aug 15, 2025, 3:59 PM
8.26
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

Nanobiotix S.A. Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
49.74M 75.28M 41.39M 83.92M
Short-Term Investments
n/a n/a 2.81M n/a
Long-Term Investments
n/a n/a n/a 98K
Other Long-Term Assets
406K 443K 291K 421K
Receivables
8.54M 2.97M 101K 6.93M
Inventory
n/a 200K 2.98M -3.04M
Other Current Assets
-1K 6.53M 7.89M n/a
Total Current Assets
61.47M 87.34M 52.36M 93.06M
Property-Plant & Equipment
5.54M 6.11M 7.12M 8.19M
Goodwill & Intangibles
7K 8K 1K 4K
Total Long-Term Assets
5.95M 6.56M 7.41M 8.71M
Total Assets
67.42M 93.9M 59.77M 101.77M
Account Payables
4.48M 6.7M 4M 5M
Deferred Revenue
18.16M n/a 16.57M 16.52M
Short-Term Debt
3.66M 3.82M 3.6M 7.08M
Other Current Liabilities
8.27M 19.86M 17.75M 17.34M
Total Current Liabilities
58.94M 49.87M 37.94M 36.84M
Long-Term Debt
43.01M 41.66M 44.04M 32.42M
Other Long-Term Liabilities
28.21M 325K 270K 318K
Total Long-Term Liabilities
74.19M 45.87M 48.88M 38.13M
Total Liabilities
133.12M 95.74M 86.81M 74.98M
Total Debt
50.9M 50.56M 53.17M 46.02M
Common Stock
1.42M 1.41M 1.05M 1.04M
Retained Earnings
-68.13M -39.7M -57.04M -47M
Comprehensive Income
-311.51M -276.07M -226.58M -182.82M
Shareholders Equity
-65.7M -1.84M -27.05M 26.79M
Total Investments
n/a n/a 2.81M 98K